EDGAR Filing Documents for 0001104659-23-050338

Form 8-K - Current report:

SEC Accession No. 0001104659-23-050338

Filing Date

2023-04-26

Accepted

2023-04-26 16:06:14

Documents

Period of Report

2023-04-20

Items

Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Interactive Data

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 8-K	tm2313709d1_8k.htm iXBRL	8-K	41189
2	EXHIBIT 4.1	tm2313709d1_ex4-1.htm	EX-4.1	98533
3	EXHIBIT 4.2	tm2313709d1_ex4-2.htm	EX-4.2	93338
4	EXHIBIT 5.1	tm2313709d1_ex5-1.htm	EX-5.1	13691
5	EXHIBIT 10.1	tm2313709d1_ex10-1.htm	EX-10.1	234264
6	EXHIBIT 99.1	tm2313709d1_ex99-1.htm	EX-99.1	10081
10	GRAPHIC	tm2313709d1_ex5-1img001.jpg	GRAPHIC	3428
11	GRAPHIC	tm2313709d1_ex5-1img002.jpg	GRAPHIC	7967
	Complete submission text file	0001104659-23-050338.txt		801111

Data Files

Seq	Description	Document	Type	Size
7	XBRL TAXONOMY EXTENSION SCHEMA	rsls-20230420.xsd	EX-101.SCH	3066
8	XBRL TAXONOMY EXTENSION LABEL LINKBASE	rsls-20230420_lab.xml	EX-101.LAB	34476
9	XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE	rsls-20230420_pre.xml	EX-101.PRE	22617
13	EXTRACTED XBRL INSTANCE DOCUMENT	tm2313709d1_8k_htm.xml	XML	3493

Mailing Address 1001 CALLE AMANECER SAN CLEMENTE CA 92673

Business Address 1001 CALLE AMANECER SAN CLEMENTE CA 92673 949-429-6680

ReShape Lifesciences Inc. (Filer) CIK: 0001427570 (see all company filings)